NCT00254982 Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00251641 The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00249808 A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies Status COMPLETED Phase PHASE4
NCT00244842 Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00237887 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00236119 Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis Status COMPLETED Phase PHASE2
NCT00235820 Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00235625 Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris Status COMPLETED Phase PHASE2
NCT00230529 A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis Status COMPLETED Phase PHASE2
NCT00224562 The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists Status UNKNOWN Phase N/A
NCT00217009 Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases. Status TERMINATED Phase EARLY_PHASE1
NCT00205465 Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765 Status COMPLETED Phase PHASE2
NCT00195676 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00195507 Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis Status COMPLETED Phase PHASE4
NCT00192517 Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00192452 Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis Status COMPLETED Phase PHASE2